| 1 | 1 | | IV |
|---|
| 2 | 2 | | 119THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION H. RES. 396 |
|---|
| 5 | 5 | | Expressing support for the designation of the week of May 4, 2025, through |
|---|
| 6 | 6 | | May 10, 2025, as ‘‘Tardive Dyskinesia Awareness Week’’. |
|---|
| 7 | 7 | | IN THE HOUSE OF REPRESENTATIVES |
|---|
| 8 | 8 | | MAY7, 2025 |
|---|
| 9 | 9 | | Mr. P |
|---|
| 10 | 10 | | ETERS(for himself, Mr. BILIRAKIS, Mr. MULLIN, and Mr. BEANof |
|---|
| 11 | 11 | | Florida) submitted the following resolution; which was referred to the |
|---|
| 12 | 12 | | Committee on Energy and Commerce |
|---|
| 13 | 13 | | RESOLUTION |
|---|
| 14 | 14 | | Expressing support for the designation of the week of May |
|---|
| 15 | 15 | | 4, 2025, through May 10, 2025, as ‘‘Tardive Dyskinesia |
|---|
| 16 | 16 | | Awareness Week’’. |
|---|
| 17 | 17 | | Whereas many people living with serious mental illnesses (for |
|---|
| 18 | 18 | | example, bipolar disorder, major depressive disorder, |
|---|
| 19 | 19 | | schizophrenia, and schizoaffective disorder) or gastro- |
|---|
| 20 | 20 | | intestinal disorders (for example, gastroparesis, upset |
|---|
| 21 | 21 | | stomach, nausea, and vomiting) may be treated with |
|---|
| 22 | 22 | | medications that work as dopamine receptor blocking |
|---|
| 23 | 23 | | agents, including antipsychotics and antiemetics; |
|---|
| 24 | 24 | | Whereas, while ongoing treatment with these medications can |
|---|
| 25 | 25 | | be necessary, prolonged use may be associated with |
|---|
| 26 | 26 | | tardive dyskinesia (TD), an involuntary movement dis- |
|---|
| 27 | 27 | | order that is characterized by uncontrollable, abnormal, |
|---|
| 28 | 28 | | VerDate Sep 11 2014 23:54 May 07, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR396.IH HR396 |
|---|
| 29 | 29 | | kjohnson on DSK7ZCZBW3PROD with $$_JOB 2 |
|---|
| 30 | 30 | | •HRES 396 IH |
|---|
| 31 | 31 | | and repetitive movements of the face, torso, limbs, and |
|---|
| 32 | 32 | | fingers or toes; |
|---|
| 33 | 33 | | Whereas even mild symptoms of TD can impact people phys- |
|---|
| 34 | 34 | | ically, socially, and emotionally; |
|---|
| 35 | 35 | | Whereas it is estimated that TD affects approximately |
|---|
| 36 | 36 | | 600,000 people in the United States, and approximately |
|---|
| 37 | 37 | | 65 percent of people with TD have not been diagnosed, |
|---|
| 38 | 38 | | making it important to raise awareness about the symp- |
|---|
| 39 | 39 | | toms; |
|---|
| 40 | 40 | | Whereas it is important that people taking these medications |
|---|
| 41 | 41 | | be monitored for TD by a health care provider, and reg- |
|---|
| 42 | 42 | | ular screening for TD is recommended by the American |
|---|
| 43 | 43 | | Psychiatric Association; |
|---|
| 44 | 44 | | Whereas clinical research has led to approval of treatments |
|---|
| 45 | 45 | | for adults with TD by the Food and Drug Administra- |
|---|
| 46 | 46 | | tion, and recognition and treatment of TD can make a |
|---|
| 47 | 47 | | positive impact in the lives of many people experiencing |
|---|
| 48 | 48 | | psychotic and mood disorders; and |
|---|
| 49 | 49 | | Whereas the House of Representatives can raise awareness of |
|---|
| 50 | 50 | | TD among the public and medical community: Now, |
|---|
| 51 | 51 | | therefore, be it |
|---|
| 52 | 52 | | Resolved, That the House of Representatives— 1 |
|---|
| 53 | 53 | | (1) expresses support for the designation of 2 |
|---|
| 54 | 54 | | ‘‘Tardive Dyskinesia Awareness Week’’; and 3 |
|---|
| 55 | 55 | | (2) encourages each individual in the United 4 |
|---|
| 56 | 56 | | States to become better informed about and aware 5 |
|---|
| 57 | 57 | | of tardive dyskinesia. 6 |
|---|
| 58 | 58 | | Æ |
|---|
| 59 | 59 | | VerDate Sep 11 2014 23:54 May 07, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6301 E:\BILLS\HR396.IH HR396 |
|---|
| 60 | 60 | | kjohnson on DSK7ZCZBW3PROD with $$_JOB |
|---|